Story
We are an independent, fully-privately owned pharmaceutical company.
Our offices are in Vienna.
We acquire, develop and supply established medical products in Europe.
Acquire. Manufacture. Market.
We acquire established branded healthcare products from multinational and speciality pharmaceutical companies
Develop. Manufacture. Market.
With new formulations and new markets, we develop healthcare products in well-defined therapeutic areas
Partner
We build partnerships to expand our portfolio. We offer a nimble approach to partnering and collaboration. We have good knowledge of central European healthcare markets and access to key medical opinion leaders.
Quality
We follow and implement high standards of quality and excellence
Products
Finished Dosage Forms
Anti Infectives and Vitamins
Active Pharmaceutical Ingredients (APIs)
Sulfametrole
Sulfametrole combined with trimethoprim shows bactericidal and fungicidal activity (Pneumocystis jirovecii). The spectrum of activity of the combination covers gram-positive and gram-negative microorganisms.
Partner with us
For vendors
We understand well the requirements of vendors to conduct transactions efficiently
Offer process
We have experience and detailed knowledge of international M & A transactions. We understand what matters and we execute quickly
During transfer
We have good actual experience of asset transfers and will ensure efficient transition
After transfer
We invest in the brands and ensure that they remain available to patients as a proven therapy option
For partners
We have country-specific expertise in Europe. We offer a range of services, including supply and commercialisation and market access.
We are interested in products for well-defined niche markets and for therapeutic areas we are currently active in.
Partnering opportunities
We are looking for knowledgeable partners to market and commercialise our products in the Americas, Asia-Pacific and Africa.
Team
Simon Adler
Simon has over 12 years of experience in pharmaceutical and healthcare management. Before that, he worked for 10 years in Investment Banking at Lehman Brothers and UBS Investment Bank (formerly S.G. Warburg) in London where he advised in senior roles on a variety of M & A and equity transactions. His sector focus included healthcare and biotechnology and the geographical focus Central and Southern Europe.
Whilst working for Medichron Simon met Gerfried Nell and decided to set up a speciality pharma business together. Simon completed his doctoral studies at the University of Cambridge (Fitzwilliam College) and obtained a Masters degree in Economics from the College of Europe in Bruges. Simon is member of the Executive Board of the Leo Baeck Institute London.
Gerfried Nell
Gerfried has over 30 years of experience in international pharma. Before founding Rokitan with Simon, he set up NPC Connect assisting pharmaceutical companies in medical, regulatory and market access affairs. He also acted as a senior clinical investigator. Before, Gerfried worked at Ciba-Geigy and Novartis Austria as Medical Director in charge of clinical research, registration, reimbursement, pharmacovigilance, quality assurance and medical affairs. Previously, he was with Eli Lilly (Indianapolis, USA) and Altana (Konstanz, Germany) as senior medical researcher in Clinical Pharmacology.
Gerfried was educated at the Medical University of Vienna where he received his PhD in medicine. Subsequently, he was awarded a Professorship at Saarland University and worked as senior lecturer in pharmacology. Gerfried is a senior member of IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine).
Contact
Please get in touch with us
+43 1 216 32 75
Grosse Mohrengasse 10, 1020 Wien
office@rokitan.com
If you want to report an adverse event or product complaint please use the contact details above.
Wenn Sie eine Nebenwirkung oder einen Qualitätsmangel melden möchten, nutzen Sie bitte auch die oben genannten Kontaktdaten.
Datenschutzerklärung (Data privacy statement as required by EU law)
VAT No. (UID): ATU 63291217
Company Registration Number: FN 290019 z